Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Eurozone GDP data lifts markets as resource stocks rise

Fri, 13th Feb 2015 11:37

Stronger-than-expected Eurozone growth figures and easing concerns about Ukraine and Greece gave stocks a boost in London on Friday, with resource shares leading the advance.The FTSE 100 was trading 0.6% higher at 6,869 by midday, as metal and oil stocks tracked commodity prices higher.Eurozone gross domestic product (GDP) growth picked up to 0.3% in the fourth quarter of 2014 from 0.2% in the third quarter, surprising analysts who had expected the rate of expansion to remain unchanged.German GDP came in particularly strong, expanding by 0.7% in the fourth quarter from 0.1% the preceding three months, well ahead of the 0.3% growth predicted in Europe's largest economy.The better-than-expected data will come as welcome news for the European Central Bank president Mario Draghi, who faced an uphill task in trying to steer the Eurozone out of deflation."Mario Draghi has bought himself a bit of time, as year-on-year figures show small signs of Eurozone growth following the significant bond buying programme he announced recently," Dennis de Jong, managing director at UFX.com.Concerns about the Ukraine crisis have also eased after the country agreed to a ceasefire with Russia after tense negotiations in Minsk. However, there was continued fighting overnight in the rebel-held cities of eastern Ukraine, with the ceasefire not expected to kick in until Sunday."Investors also appear confident that a Greek disaster can also be averted on unconfirmed reports that German and Greek officials were working on a compromise in Brussels as both sides looked to soften their positions," said analyst Michael Hewson from CMC Markets. The speculation comes before the next Eurogroup meeting scheduled to begin on Monday.Anglo leads miners higherThe share price of Anglo American advanced despite the news that it has decided to write-down the value of certain assets by $3.9bn on the back of weaker iron ore prices, pushing the company into the red for the 2014 financial year. Anglo swung to a pre-tax loss of $259m in 2014, compared with a profit of $1.7bn in 2013.Other miners were also in positive territory, including BHP Billiton, Glencore and Rio Tinto, as metal prices improved. Even Fresnillo gained despite explaining how foreign exchange movements, depreciation and write-downs would adversely affect its 2014 results.Oil stocks such as Tullow, BG and Premier Oil were also in demand was Brent crude continued its rebound and was trading above $60 a a barrel for the first time in 2015.Glaxosmithkline's shares were given a boost by UBS which upgraded its rating for the pharmaceutical stock by two notches from 'sell' to 'buy', saying that the business is now at an "inflection point" after a tough few years. The bank hiked its target price for the stock from 1,250p to 1,700p,Utilities group Severn Trent declined after saying that while it is on track to hit expectations this financial year, operating costs are expected to rise due to the impact of inflation and quasi taxes.Rolls-Royce also fell despite the engine maker meeting forecasts with its 2014 results, as it said it expects profits to fall further this year as customers face "increased uncertainty" from weaker oil prices.Shire edged higher after a strong jump the previous session following its fourth-quarter results. The pharma group was also in focus on speculation it is preparing to make a bid for US peer Salix Pharmaceuticals, worth $9.2bn at current market prices.Market MoverstechMARK 3,126.19 +0.32%FTSE 100 6,869.16 +0.60%FTSE 250 16,894.80 +0.51%FTSE 100 - RisersTullow Oil (TLW) 403.20p +4.70%Glencore (GLEN) 288.30p +4.12%BHP Billiton (BLT) 1,554.00p +3.98%GlaxoSmithKline (GSK) 1,544.50p +3.97%Anglo American (AAL) 1,206.50p +3.52%Rio Tinto (RIO) 3,139.00p +3.27%Antofagasta (ANTO) 728.50p +3.26%BG Group (BG.) 962.80p +3.04%Weir Group (WEIR) 1,889.00p +2.66%Barclays (BARC) 258.75p +2.13%FTSE 100 - FallersBT Group (BT.A) 440.10p -2.20%United Utilities Group (UU.) 954.00p -1.95%easyJet (EZJ) 1,708.00p -1.95%InterContinental Hotels Group (IHG) 2,623.00p -1.58%SSE (SSE) 1,577.00p -1.44%ARM Holdings (ARM) 1,070.00p -1.38%Ashtead Group (AHT) 1,086.00p -1.27%National Grid (NG.) 883.50p -1.24%Severn Trent (SVT) 2,033.00p -1.17%Sage Group (SGE) 469.70p -1.05%FTSE 250 - RisersAfren (AFR) 8.26p +16.17%Vedanta Resources (VED) 523.50p +10.68%Premier Oil (PMO) 167.70p +5.54%RPS Group (RPS) 239.20p +5.42%Kaz Minerals (KAZ) 256.80p +4.26%Evraz (EVR) 194.30p +3.74%BlackRock World Mining Trust (BRWM) 331.60p +3.46%Atkins (WS) (ATK) 1,355.00p +3.04%Lonmin (LMI) 161.60p +2.93%Oxford Instruments (OXIG) 735.50p +2.87%FTSE 250 - FallersAO World (AO.) 285.90p -6.14%Supergroup (SGP) 1,022.00p -3.49%Bwin.party Digital Entertainment (BPTY) 99.05p -3.37%Acacia Mining (ACA) 273.40p -2.74%Hunting (HTG) 494.10p -1.77%Ocado Group (OCDO) 385.00p -1.53%Euromoney Institutional Investor (ERM) 985.00p -1.50%Go-Ahead Group (GOG) 2,422.00p -1.30%Rank Group (RNK) 184.70p -1.23%TalkTalk Telecom Group (TALK) 319.90p -1.17%
More News
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more
4 Jan 2024 14:01

UK dividends calendar - next 7 days

Friday 5 January 
British Land Co PLCdividend payment date
Hill & Smith PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Lok'n Store Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
RS Group PLCdividend payment date
Tate & Lyle PLCdividend payment date
Monday 8 January 
abrdn Equity Income Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
Tuesday 9 January 
no events scheduled 
Wednesday 10 January 
Assura PLCdividend payment date
Bellway PLCdividend payment date
Fidelity Special Values PLCdividend payment date
LXi REIT PLCdividend payment date
Severn Trent PLCdividend payment date
Volex PLCdividend payment date
Vp PLCdividend payment date
Thursday 11 January 
AJ Bell PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
CMC Markets PLCdividend payment date
dotdigital Group PLCex-dividend payment date
Ecora Resources PLCex-dividend payment date
European Assets Trust PLCex-dividend payment date
Foresight Group Holdings Ltdex-dividend payment date
GSK PLCdividend payment date
ICG-Longbow Senior Secured UK Property Debt Investments Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
Keystone Positive Change Investment Trust PLCex-dividend payment date
LondonMetric Property PLCdividend payment date
Murray International Trust PLCex-dividend payment date
National Grid PLCdividend payment date
Primary Health Properties PLCex-dividend payment date
Sage Group PLCex-dividend payment date
Smiths News PLCex-dividend payment date
SSE PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
TR Property Investment Trust PLCdividend payment date
Walker Crips Group PLCex-dividend payment date
WH Smith PLCex-dividend payment date
Worldwide Healthcare Trust PLCdividend payment date
XPS Pensions Group PLCex-dividend payment date
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.